Real Time Optical Coherence Tomography (OCT) of Human Tissue

Stopped early

Conditions studied: Breast Cancer

In brief

This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.

Key facts

Study ID

NCT01506700

Run by

Diagnostic Photonics, Inc.

People needed

5

Starts

2012-05-01

Expected to finish

2019-07-17

Last updated by the study team

2019-07-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women 18 years of age or older
• Signed ICF
• Women who have been histologically diagnosed with invasive ductal carcinoma or invasive lobular carcinoma of the breast prior to surgery
• Planning breast preservation
• Patients undergoing lumpectomy (partial mastectomy) procedure

You may not qualify if…

• Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)
• Neoadjuvant systemic therapy
• All T4 tumors
• Previous radiation in the operated breast
• Prior surgical procedure in the same quadrant
• Implants in the operated breast
• Pregnancy
• Lactation
• Participating in any other investigational study for either drug or device which can influence collection of valid data under this study

Where it is running

• Carle Foundation Hospital — Urbana, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.